T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Alcon
ALC
|
+$2.23B |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$1.45B |
| 3 |
Linde
LIN
|
+$1.44B |
| 4 |
American International
AIG
|
+$1.43B |
| 5 |
Marvell Technology
MRVL
|
+$1.31B |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$2.31B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.58B |
| 4 |
Eli Lilly
LLY
|
+$1.54B |
| 5 |
Booking.com
BKNG
|
+$1.17B |
Sector Composition
| 1 | Technology | 18.89% |
| 2 | Healthcare | 16.97% |
| 3 | Financials | 13.8% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
NewMarket
NEU
$7.93B
| $31.5M | ﹤0.01% |
78,680
+11,878
| +18% | +$4.76M |
|
|
RAVN
1027
DELISTED
Raven Industries Inc
RAVN
| $31.5M | ﹤0.01% |
877,033
-352,162
| -29% | -$12.6M |
|
1028
CytomX Therapeutics
CTMX
$335M
| $31.4M | ﹤0.01% |
2,800,872
-289,801
| -9% | -$3.25M |
|
|
PCSB
1029
DELISTED
PCSB Financial Corporation
PCSB
| $31.3M | ﹤0.01% |
1,547,625
+39,896
| +3% | +$808K |
|
|
DTV
1030
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
| $31.2M | ﹤0.01% |
556,505
-596,939
| -52% | -$33.5M |
|
1031
Labcorp
LH
$23.2B
| $31.2M | ﹤0.01% |
209,933
+109
| +0.1% | +$16.2K |
|
1032
Utah Medical Products
UTMD
$201M
| $31.2M | ﹤0.01% |
325,664
+9,510
| +3% | +$910K |
|
1033
Cirrus Logic
CRUS
$6.01B
| $30.9M | ﹤0.01% |
707,238
-392
| -0.1% | -$17.1K |
|
1034
Coty
COTY
$3.6B
| $30.8M | ﹤0.01% |
2,300,142
-3,302,524
| -59% | -$44.3M |
|
1035
lululemon athletica
LULU
$19.1B
| $30.7M | ﹤0.01% |
170,509
+16,730
| +11% | +$3.01M |
|
|
PRNB
1036
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $30.6M | ﹤0.01% |
922,952
+8,970
| +1% | +$298K |
|
1037
Hercules Capital
HTGC
$3.53B
| $30.6M | ﹤0.01% |
2,388,538
-235,397
| -9% | -$3.02M |
|
|
ALLK
1038
DELISTED
Allakos
ALLK
| $30.6M | ﹤0.01% |
706,359
-60,126
| -8% | -$2.61M |
|
1039
CMS Energy
CMS
$21.5B
| $30.6M | ﹤0.01% |
528,412
-332,422
| -39% | -$19.3M |
|
1040
Advanced Energy
AEIS
$5.95B
| $30.6M | ﹤0.01% |
543,353
+15,658
| +3% | +$881K |
|
1041
Culp
CULP
$59.6M
| $30.5M | ﹤0.01% |
1,606,921
-16,678
| -1% | -$317K |
|
1042
Henry Schein
HSIC
$8.38B
| $30.4M | ﹤0.01% |
435,167
-349,233
| -45% | -$24.4M |
|
1043
National Vision
EYE
$1.83B
| $30.2M | ﹤0.01% |
983,059
-2,878,890
| -75% | -$88.5M |
|
1044
Jazz Pharmaceuticals
JAZZ
$7.69B
| $30.1M | ﹤0.01% |
211,312
-1,991
| -0.9% | -$284K |
|
1045
Viatris
VTRS
$11.7B
| $30.1M | ﹤0.01% |
1,581,174
-182,361
| -10% | -$3.47M |
|
|
CBM
1046
DELISTED
Cambrex Corporation
CBM
| $30.1M | ﹤0.01% |
642,151
-1,912
| -0.3% | -$89.5K |
|
1047
Stitch Fix
SFIX
$720M
| $30M | ﹤0.01% |
938,242
-372,360
| -28% | -$11.9M |
|
|
RWT
1048
Redwood Trust
RWT
$804M
| $30M | ﹤0.01% |
1,812,349
-66,784
| -4% | -$1.1M |
|
1049
American Vanguard Corp
AVD
$159M
| $29.9M | ﹤0.01% |
1,941,870
-13,089
| -0.7% | -$202K |
|
1050
Lennar Class A
LEN
$35.8B
| $29.9M | ﹤0.01% |
636,518
-5,019
| -0.8% | -$235K |
|